Skip to main content
. 2017 Jun 7;38(9):4430–4443. doi: 10.1002/hbm.23670

Table 1.

Demographic and Behavioral Data

HC (n = 41) PD (n = 41)
mean ± se mean ± se P value
Age (years) 23.09 ± 0.44 24.02 ± 0.51 >0.05
Education (years) 18.01 ± 0.1 18.02 ± 0.13 >0.05
Cycles (days) 29.21 ± 0.17 29.44 ± 0.19 >0.05
Age at menarche (years) 12.21 ± 0.67 12.46 ± 0.84 >0.05
History of menstrual pain (years) 10.49 ± 1.1
Duration of menstrual pain (days) 1.9 ± 0.38
Drug taken (%) 21%
Periovulatory phase
PGF 2α 7.22 ± 0.7 10.58 ± 1.33 >0.05
VAS 0 0
SAS 26.5 ± 1.0 28.24 ± 1.28 >0.05
SDS 27.1 ± 1.9 28.92 ± 1.16 >0.05
Menstruation phase
PGF 2α 6.96 ± 0.65 11.68 ± 1.16 <0.00001
VAS 0.34 ± 0.12 6.5 ± 0.23 <0.00001
SAS 27 ± 1.33 32.28 ± 1.8 >0.05
SDS 28.8 ± 1.58 34.36 ± 1.95 >0.05

PD, primary dysmenorrhea; HC, healthy controls; PGF 2α, prostaglandins F 2α; VAS, visual analogue scale; SAS, self‐rating anxiety scale; SDS, self‐rating distress scale; se, standard error.

The comparisons of subjects' basic information were performed between PDM and HC groups using two‐sample t test. P < 0.05 was considered significant. False discovery rate (FDR) was used to correct for multiple comparisons.